Total 424
발표행사
대분류
중분류
* 해당게시물은 유방암학회 저작물입니다. 불법 복사나, 다운로드를 금합니다.
Polly Suk Yee Cheung
(Hong Kon Sanatorium and Hospital)
Hong Kong
Optimal duration of endocrine therapy
Polly Suk Yee Cheung (Hong Kon Sanatorium and Hospital)
Tadahiko Shien
(Okayama University Hospital)
Japan
The role of CDK4/6 inhibitors in ER+/HER2- early breast cancer
Tadahiko Shien (Okayama University Hospital)
Peter C. Dubsky
(Hirslanden Klinik St. Anna)
Switzerland
ER+/HER2- premenopausal breast cancer - the biomarker way forward
Peter C. Dubsky (Hirslanden Klinik St. Anna)
Chee Hao Lester Leong
(Singapore General Hospital)
Singapore
Screening and assessment of breast cancer in older women
Chee Hao Lester Leong (Singapore General Hospital)
Jee Hyun Kim
(Seoul National University Bundang Hospital)
Korea
Systemic therapy for older breast cancer patients
Jee Hyun Kim (Seoul National University Bundang Hospital)
Tristen Park
(Yale School of Medicine)
U.S.A.
Surgical therapy for older breast cancer patient
Tristen Park (Yale School of Medicine)
Beatriu Reig
(NYU Langone Health)
Causes of over- and underestimation of tumor and axillary LN after neoadjuvant system therapy
Beatriu Reig (NYU Langone Health)
Masako Kataoka
(Kyoto University)
Evaluation of response to neoadjuvant systemic therapy: Multiparametric approach for accurate evaluation of residual tumor
Masako Kataoka (Kyoto University)
Sung Hun Kim
(The Catholic University of Korea, Seoul St. Mary's Hospital)
How to manage residual microcalcifications after neoadjuvant chemotherapy
Sung Hun Kim (The Catholic University of Korea, Seoul St. Mary's Hospital)
Isabel T. Rubio
(Clinica Universidad de Navarra)
Spain
Management of hereditary breast cancer in Europe
Isabel T. Rubio (Clinica Universidad de Navarra)
Quik Menu
